Published in J Gen Virol on November 01, 2006
Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog (2010) 1.67
Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol (2011) 1.60
Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants. PLoS One (2016) 1.42
Prevalence and genetic diversity analysis of human coronavirus OC43 among adult patients with acute respiratory infections in Beijing, 2012. PLoS One (2014) 0.80
Cleavage of a Neuroinvasive Human Respiratory Virus Spike Glycoprotein by Proprotein Convertases Modulates Neurovirulence and Virus Spread within the Central Nervous System. PLoS Pathog (2015) 0.77
Genomic Analysis of 15 Human Coronaviruses OC43 (HCoV-OC43s) Circulating in France from 2001 to 2013 Reveals a High Intra-Specific Diversity with New Recombinant Genotypes. Viruses (2015) 0.76
Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia. Virol J (2016) 0.76
Isolation and Characterization of Dromedary Camel Coronavirus UAE-HKU23 from Dromedaries of the Middle East: Minimal Serological Cross-Reactivity between MERS Coronavirus and Dromedary Camel Coronavirus UAE-HKU23. Int J Mol Sci (2016) 0.75
Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: phylogenetic, spatiotemporal and transmission network analyses. Emerg Microbes Infect (2017) 0.75
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet (2013) 4.57
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog (2008) 2.49
Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology (2007) 2.49
Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med (2002) 2.48
Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol (2008) 2.29
Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol (2006) 2.01
Avian Influenza A virus polymerase association with nucleoprotein, but not polymerase assembly, is impaired in human cells during the course of infection. J Virol (2008) 1.92
An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Clin Infect Dis (2003) 1.88
Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. Intensive Care Med (2005) 1.58
Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis (2003) 1.58
Global genetic diversity of human metapneumovirus fusion gene. Emerg Infect Dis (2004) 1.53
Detection of the new human coronavirus HKU1: a report of 6 cases. Clin Infect Dis (2006) 1.51
Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol (2007) 1.51
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J Virol (2005) 1.47
Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med (2014) 1.45
April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes Infect (2009) 1.40
Water-borne transmission drives avian influenza dynamics in wild birds: the case of the 2005-2006 epidemics in the Camargue area. Infect Genet Evol (2009) 1.39
Human coronavirus NL63, France. Emerg Infect Dis (2005) 1.33
Measles elimination efforts and 2008-2011 outbreak, France. Emerg Infect Dis (2013) 1.28
Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA). PLoS One (2009) 1.28
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med (2010) 1.24
Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis (2003) 1.22
A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine (2009) 1.18
A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol Lett (2003) 1.17
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol (2005) 1.16
Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France. J Paediatr Child Health (2007) 1.14
In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One (2009) 1.13
Introduction of SARS in France, March-April, 2003. Emerg Infect Dis (2004) 1.10
Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase. Nat Commun (2010) 1.08
Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network. J Infect Dis (2012) 1.07
Re-emergence of measles among young adults in Marseilles, France. Eur J Epidemiol (2004) 1.06
Human respiratory coronavirus OC43: genetic stability and neuroinvasion. J Virol (2004) 1.06
Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis (2009) 1.05
Spread of avian influenza viruses by common teal (Anas crecca) in Europe. PLoS One (2009) 1.05
Development of a PCR-and hybridization-based assay (PCR Adenovirus Consensus) for the detection and the species identification of adenoviruses in respiratory specimens. J Clin Virol (2004) 1.00
Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus. Antivir Ther (2007) 0.99
Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun (2009) 0.99
Standardization and validation of assays determining cellular immune responses against influenza. Vaccine (2010) 0.98
Use of a multiplex PCR/RT-PCR approach to assess the viral causes of influenza-like illnesses in Cambodia during three consecutive dry seasons. J Med Virol (2010) 0.98
I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y. PLoS One (2012) 0.98
Replication of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line. J Med Virol (2005) 0.97
Viral epidemiology and severity of respiratory infections in infants in 2009: a prospective study. Pediatr Infect Dis J (2012) 0.96
Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution. Antivir Ther (2011) 0.96
Human parainfluenza virus type 4 infections: a report of 20 cases from 1998 to 2002. J Clin Virol (2005) 0.95
Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One (2011) 0.94
Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter. Virology (2003) 0.94
Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient. J Clin Microbiol (2009) 0.93
Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections. PLoS One (2013) 0.93
Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One (2010) 0.91
Rescue of influenza C virus from recombinant DNA. J Virol (2007) 0.91
Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells. Vet Microbiol (2009) 0.91
Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5' terminal sequence: induction of heterospecific B and T cell responses in mice. Virology (2005) 0.91
Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC Infect Dis (2008) 0.90
Detection of human bocavirus in hospitalised children. J Paediatr Child Health (2009) 0.90
Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study. Crit Care (2006) 0.89
Influenza A virus in birds during spring migration in the Camargue, France. J Wildl Dis (2007) 0.88
Genotyping measles virus by real-time amplification refractory mutation system PCR represents a rapid approach for measles outbreak investigations. J Clin Microbiol (2006) 0.87
Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol (2003) 0.87
Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes. Vaccine (2011) 0.87
Natural polymorphism of cytomegalovirus DNA polymerase lies in two nonconserved regions located between domains delta-C and II and between domains III and I. Antimicrob Agents Chemother (2004) 0.86
Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes. Virol J (2008) 0.86
Avian influenza circulation in the Camargue (south of France) during the 2006-07 season. Avian Dis (2010) 0.85
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination. J Immunol (2013) 0.84
H9N2 avian influenza virus in a Mediterranean gull. J Mol Genet Med (2008) 0.84
Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43. J Virol Methods (2006) 0.84
High influenza a virus infection rates in Mallards bred for hunting in the Camargue, South of France. PLoS One (2012) 0.84
HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine (2012) 0.83
Algorithm-based prediction of HIV-1 subtype D coreceptor use. J Clin Microbiol (2013) 0.83
[Measles in France]. Med Sci (Paris) (2012) 0.83
Absence of detection of highly pathogenic H5N1 in migratory waterfowl in southern France in 2005-2006. Infect Genet Evol (2007) 0.82
Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 Variants. J Acquir Immune Defic Syndr (2016) 0.82
Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study. BMC Infect Dis (2009) 0.82
Rapid molecular diagnosis of measles virus infection in an epidemic setting. J Med Virol (2013) 0.82
Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France. PLoS One (2012) 0.82
Coronavirus: need for a therapeutic approach. Lancet Infect Dis (2013) 0.81